European Pharmaceutical Market Access, Pricing & Reimbursement Conference


Conference: 10th October to 11th October 2016
Workshops: 12th October 2016
Holiday Inn Kensington Forum, London, United Kingdom

SMi Group’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference returns to London from 10-11 October 2016. The conference is one of the most established in the world, focusing on the changes in pricing and reimbursement and market access.

Key topics include:
• Updates on AMNOG and its implication on pricing and reimbursement
• How biosimilars are affecting your pricing strategy
• Capture on emerging markets’ regulatory framework to adapt your market access and P&R models
• Orphan drugs using recent examples to highlight the impact on pricing
• Cancer drug funding and budget cuts in the UK
• Innovative solutions beyond the pill
• Japanese and Turkish regional updates


• Simone Breitkopf, Head HEOR, Governmental and Public Affairs, Alcon
• Ulf Staginnus, Head Market Access Oncology, Region Europe, Baxalta
• Gordon Spencer, Regional Market Access Lead – EU & Canada, Shire International GmbH
• Alexander Natz, Secretary General, EUCOPE
• David Watson, Director of Pricing and PPRS, Association of the British Pharmaceutical Industry
• Panos Kefalas, Head of Health Economics and Market Access, Cell & Gene Therapy Catapult
• Ken Walsh, Senior Principal, Global Payer Strategy Consulting, Evidera

The conference will feature two exclusive post-conference workshops:

A: HTA and reimbursement decisions for innovative medicines
Workshop Leader: Patrick Mollon, Former Director Global Health Economics & Outcomes Research, Novartis; HEOR Director, PMHE2020

B: Managing the global to local challenge
Workshop Leader: Janice Haigh, Practice Leader, Quintiles

For more information please visit:

To register: contact Fateja Begum on +44 (0)20 7827 6184 or email: